Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
3 "Sunny H. Wong"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
IBD
Helminths in alternative therapeutics of inflammatory bowel disease
Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal
Intest Res 2025;23(1):8-22.   Published online January 12, 2024
DOI: https://doi.org/10.5217/ir.2023.00059
AbstractAbstract PDFPubReaderePub
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a nonspecific chronic inflammation of the gastrointestinal tract. Despite recent advances in therapeutics and newer management strategies, IBD largely remains untreatable. Helminth therapy is a promising alternative therapeutic for IBD that has gained some attention in the last two decades. Helminths have immunomodulatory effects and can alter the gut microbiota. The immunomodulatory effects include a strong Th2 immune response, T-regulatory cell response, and the production of regulatory cytokines. Although concrete evidence regarding the efficacy of helminth therapy in IBD is lacking, clinical studies and studies done in animal models have shown some promise. Most clinical studies have shown that helminth therapy is safe and easily tolerable. Extensive work has been done on the whipworm Trichuris, but other helminths, including Schistosoma, Trichinella, Heligmosomoides, and Ancylostoma, have also been explored for pre-clinical and animal studies. This review article summarizes the potential of helminth therapy as an alternative therapeutic or an adjuvant to the existing therapeutic procedures for IBD treatment.
  • 4,535 View
  • 345 Download
Close layer
IBD
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Himani Pandey, Dheeraj Jain, Daryl W. T. Tang, Sunny H. Wong, Devi Lal
Intest Res 2024;22(1):15-43.   Published online November 8, 2023
DOI: https://doi.org/10.5217/ir.2023.00080
AbstractAbstract PDFPubReaderePub
Inflammatory bowel disease (IBD) is a multifactorial disease, which is thought to be an interplay between genetic, environment, microbiota, and immune-mediated factors. Dysbiosis in the gut microbial composition, caused by antibiotics and diet, is closely related to the initiation and progression of IBD. Differences in gut microbiota composition between IBD patients and healthy individuals have been found, with reduced biodiversity of commensal microbes and colonization of opportunistic microbes in IBD patients. Gut microbiota can, therefore, potentially be used for diagnosing and prognosticating IBD, and predicting its treatment response. Currently, there are no curative therapies for IBD. Microbiota-based interventions, including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, have been recognized as promising therapeutic strategies. Clinical studies and studies done in animal models have provided sufficient evidence that microbiota-based interventions may improve inflammation, the remission rate, and microscopic aspects of IBD. Further studies are required to better understand the mechanisms of action of such interventions. This will help in enhancing their effectiveness and developing personalized therapies. The present review summarizes the relationship between gut microbiota and IBD immunopathogenesis. It also discusses the use of gut microbiota as a noninvasive biomarker and potential therapeutic option.

Citations

Citations to this article as recorded by  
  • Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement
    Great Iruoghene Edo, Alice Njolke Mafe, Ali B.M. Ali, Patrick Othuke Akpoghelie, Emad Yousif, Jesse Innocent Apameio, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Yasal Garba, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Umar, Dilber Uzun Oz
    International Journal of Biological Macromolecules.2025; 289: 138633.     CrossRef
  • Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release
    Great Iruoghene Edo, Alice Njolke Mafe, Nawar. F. Razooqi, Ebuka Chukwuma Umelo, Tayser Sumer Gaaz, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Patrick Othuke Akpoghelie, Rapheal Ajiri Opiti, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Uma
    Designed Monomers and Polymers.2025; 28(1): 1.     CrossRef
  • Helminths in alternative therapeutics of inflammatory bowel disease
    Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal
    Intestinal Research.2025; 23(1): 8.     CrossRef
  • Protective effect of low-dose lactulose in dextran sulfate sodium induced ulcerative colitis model of rats
    Min Cui, Wei-Ming Yang, Ping Yao
    Scientific Reports.2025;[Epub]     CrossRef
  • Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
    Linda Galasso, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Federica Vitale, Alberto Nicoletti, Mattia Paratore, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco
    Cancers.2025; 17(3): 368.     CrossRef
  • Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid
    Zhuoya Wang, Tian Liu, Li Liu, Jian Xie, Furui Tang, Yimin Pi, Yuchun Zhong, Zhidong He, Wenming Zhang, Cihua Zheng
    Pharmacological Research.2025; 213: 107663.     CrossRef
  • Therapeutic systems based on natural gut microbiota modulators: the latest advances in the treatment of inflammatory bowel disease
    Zelin Guan, Peilin Niu, Qichao Tan, Yidong Wang, Shujing Deng, Danyang Wang, Kai Dong, Jianfeng Xing, Cuiyu You
    Materials Advances.2025; 6(5): 1578.     CrossRef
  • Metabolic musculoskeletal disorders in patients with inflammatory bowel disease
    Young Joo Yang, Seong Ran Jeon
    The Korean Journal of Internal Medicine.2025; 40(2): 181.     CrossRef
  • Photobiomodulation and the oral-gut microbiome axis: therapeutic potential and challenges
    Neda Hakimiha, Somayeh Jahani Sherafat, E-Liisa Laakso, Reza Fekrazad
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Editorial: Environments-pathogens-the gut microbiota and host diseases
    Jinbo Xiong, Zunji Shi
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders
    Giorgio Vivacqua, Romina Mancinelli, Stefano Leone, Rosa Vaccaro, Ludovica Garro, Simone Carotti, Ludovica Ceci, Paolo Onori, Luigi Pannarale, Antonio Franchitto, Eugenio Gaudio, Arianna Casini
    Neurogastroenterology & Motility.2024;[Epub]     CrossRef
  • Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies
    Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Rahul Maheshwari, Sankha Bhattacharya, Bhupendra G. Prajapati
    ACS Pharmacology & Translational Science.2024; 7(4): 967.     CrossRef
  • Healing from Within: How Gut Microbiota Predicts IBD Treatment Success—A Systematic Review
    Luana Alexandrescu, Alina Doina Nicoara, Doina Ecaterina Tofolean, Alexandra Herlo, Andreea Nelson Twakor, Cristina Tocia, Anamaria Trandafir, Andrei Dumitru, Eugen Dumitru, Cristian Florentin Aftenie, Ionela Preotesoiu, Elena Dina, Ioan Tiberiu Tofolean
    International Journal of Molecular Sciences.2024; 25(15): 8451.     CrossRef
  • Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis
    Sara Deleu, Inge Jacobs, Jorge F. Vazquez Castellanos, Sare Verstockt, Bruna Trindade de Carvalho, Ana Subotić, Bram Verstockt, Kaline Arnauts, Lowie Deprez, Eva Vissers, Matthias Lenfant, Greet Vandermeulen, Gert De Hertogh, Kristin Verbeke, Gianluca Mat
    Nutrients.2024; 16(16): 2668.     CrossRef
  • The emerging role of the gut microbiota and its application in inflammatory bowel disease
    Xiu Wang, Jianhua Peng, Peipei Cai, Yuxuan Xia, Chengxue Yi, Anquan Shang, Francis Atim Akanyibah, Fei Mao
    Biomedicine & Pharmacotherapy.2024; 179: 117302.     CrossRef
  • Bifidogenic Effect of Human Milk Oligosaccharides on Pediatric IBD Fecal Microbiota
    Nize Otaru, Danica Bajic, Pieter Van den Abbeele, Saskia Vande Velde, Stephanie Van Biervliet, Robert E. Steinert, Ateequr Rehman
    Microorganisms.2024; 12(10): 1977.     CrossRef
  • Analysis of the Preventive Effect of Lonicera caerulea Pomace and Its Isolated Components on Colitis in Mice Based on Gut Microbiota and Serum Metabolomics
    Zinuo Zhou, Xinwen Huang, Baixi Zhang
    Antioxidants.2024; 13(12): 1478.     CrossRef
  • Gut microbiota mediated T cells regulation and autoimmune diseases
    Nabeel Khalid Bhutta, Xiujin Xu, Cuiqin Jian, Yifan Wang, Yi Liu, Jinlyu Sun, Bingnan Han, Shandong Wu, Ansar Javeed
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects
    Yibing Hu, Zhenping Wu, Xiaoyun Yang, Jin Ding, Qunying Wang, Hao Fang, Lujian Zhu, Minli Hu
    BMC Microbiology.2024;[Epub]     CrossRef
  • 10,366 View
  • 470 Download
  • 20 Web of Science
  • 19 Crossref
Close layer
Changing epidemiological trends of inflammatory bowel disease in Asia
Wee Khoon Ng, Sunny H. Wong, Siew C. Ng
Intest Res 2016;14(2):111-119.   Published online April 27, 2016
DOI: https://doi.org/10.5217/ir.2016.14.2.111
AbstractAbstract PDFPubReaderePub

Inflammatory bowel disease (IBD) has become more common in Asia over the past few decades. The rate of increase in prevalence of the disease varies greatly in Asia, with several countries in East Asia experiencing a more than doubled increase in IBD prevalence over the past decade. Historically, ulcerative colitis (UC) is more common than Crohn's disease (CD) in Asia. However, a reverse trend is beginning to appear in more developed countries in Asia such as Japan, Korea, and Hong Kong. While Asian IBD patients share many similarities with their Western counterparts, there are important differences with significant clinical implications. In Asia, there are more men with CD, more ileo-colonic involvement in CD, less familial aggregation, fewer extra-intestinal manifestations and worse clinical outcomes for older-onset patients with UC. These differences are likely related to the different genetic makeup and environmental exposures in different regions. Evaluation of the differences and rates in epidemiologic trends may help researchers and clinicians estimate disease burden and understand the reasons behind these differences, which may hold the key to unravel the etiology of IBD.

Citations

Citations to this article as recorded by  
  • Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan
    Tadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, Mitsuhiro Takeno
    Journal of Gastroenterology.2025; 60(3): 294.     CrossRef
  • Management of Anal Fistula with Crohn's Disease
    Shota Takano, Yasushi Nakamura, Kohei Tamaoka, Takafumi Yoshimoto, Yasue Irei, Yoriyuki Tsuji
    Journal of the Anus, Rectum and Colon.2025; 9(1): 10.     CrossRef
  • Key Themes in the Care of Inflammatory Bowel Diseases Among Immigrant Populations: A Systematic Review
    Michael Youssef, Parul Tandon, Tyrel Jones, Varun Srikanth, Laura Targownik
    Digestive Diseases and Sciences.2025;[Epub]     CrossRef
  • The Importance of Post-Inflammatory Polyps (PIPs) in Colorectal Cancer Surveillance in Inflammatory Bowel Diseases
    Ivanna Candel, Panu Wetwittayakhlang, Talat Bessissow, Peter L. Lakatos
    Journal of Clinical Medicine.2025; 14(2): 333.     CrossRef
  • Recent advances in epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years
    Jian Wan, Jiaming Zhou, Zhuo Wang, Dan Liu, Hao Zhang, Shengmao Xie, Kaichun Wu
    Chinese Medical Journal.2025;[Epub]     CrossRef
  • Evaluation of the mechanism of action of Aegle marmelos in a murine model of 3% dextran sulphate sodium induced acute colitis
    Alok Nachane, Sandhya K. Kamat, Manoj Radhakrishnan, Gita Nataraj, Sunil S. Kuyare
    International Journal of Basic & Clinical Pharmacology.2025; 14(2): 275.     CrossRef
  • Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
    Dian-yu Zheng, Yi-nuo Wang, Yu-Hong Huang, Min Jiang, Cong Dai
    International Immunopharmacology.2024; 126: 111229.     CrossRef
  • Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review
    Sudheer K Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
    Journal of Crohn's and Colitis.2024; 18(6): 836.     CrossRef
  • Efficacy and safety of moxibustion for ulcerative colitis: protocol for a systematic review and meta-analysis
    Yanzhen Li, Wen Zhou, Wenxiao Chen, Bailing Deng, Jianyu You
    BMJ Open.2024; 14(3): e078878.     CrossRef
  • Trends in the prevalence and incidence of Crohn’s disease in Japan and the United States
    Ko Nakajo, Michiyo Yamazaki, Hsingwen Chung, Youran Xu, Hong Qiu
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Rising Incidence of Inflammatory Bowel Disease in the Asian Subcontinent—An Exploration of Causative Factors
    Priyansh Bhayani, Kartik Natarajan, Nayantara Coelho-Prabhu
    Gastrointestinal Disorders.2024; 6(2): 549.     CrossRef
  • Safety and Effectiveness of Ustekinumab for Crohn’s Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan
    Katsumasa Nagano, Hiroaki Tsuchiya, Teita Asano, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
    Crohn's & Colitis 360.2024;[Epub]     CrossRef
  • Osteopontin regulation of MerTK+ macrophages promotes Crohn’s disease intestinal fibrosis
    Juanhan Liu, Wenbin Gong, Peizhao Liu, Yangguang Li, Haiyang Jiang, Cunxia Wu, Xiuwen Wu, Yun Zhao, Jianan Ren
    iScience.2024; 27(7): 110226.     CrossRef
  • A Continuous Registry of Medical Record, Patient Input, and Epidemiological Data of Patients With Ulcerative Colitis: a Multicentre, Prospective, Observational Clinical Registry Study in Japan
    Katsuyoshi Matsuoka, Shuji Hibiya, Katsuyoshi Ando, Yuji Tani, Takehiro Torisu, Haruei Ogino, Takanori Yamashita, Akira Andoh, Yoshihisa Sugimoto, Takayuki Matsumoto, Yusuke Iwanaga, Takashi Suda, Taku Kobayashi
    Annals of Clinical Epidemiology.2024; 6(3): 65.     CrossRef
  • Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study
    Chia-Jung Kuo, Cheng-Yu Lin, Puo-Hsien Le, Yao-Wei Kuo, Chen-Ming Hsu, Ming-Wei Lai, Wey-Ran Lin, Ming-Ling Chang, Ming-Yao Su, Cheng-Tang Chiu, Chee-Jen Chang
    Digestive Diseases and Sciences.2024; 69(9): 3172.     CrossRef
  • Differences of clinical phenotype between familial and sporadic Crohn’s disease in East China
    Siyuan Dong, Xiaoxia Xiang, Yu Zhang, Rongbei Liu, Lingna Ye, Qian Cao
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Predicting novel biomarkers for early diagnosis and dynamic severity monitoring of human ulcerative colitis
    Yu Chen, Li Chen, Sheng Huang, Li Yang, Li Wang, Feiyun Yang, Jinxiu Huang, Xiuliang Ding
    Frontiers in Genetics.2024;[Epub]     CrossRef
  • Concordance of phenotypic characteristics among patients with familial Crohn's disease in China
    Xiao Xia Deng, Min Zhi Lin, Xiang Gao, Xin Yu Liu, Yan Hui Wu, Kang Chao, Jian Tang
    Journal of Digestive Diseases.2024; 25(7): 444.     CrossRef
  • Effects of a Pre-Conception Care Program in Women with Inflammatory Bowel Disease: A Mixed-Methods Study Including a Randomized Controlled Trial
    Young Jin Lee, Hae Won Kim, Yeon Hee Kim, Suk-Kyun Yang, Ji-Yeon Kim
    Journal of Korean Academy of Nursing.2024; 54(3): 386.     CrossRef
  • Ulcerative colitis: molecular insights and intervention therapy
    Yuqing Liang, Yang Li, Chehao Lee, Ziwei Yu, Chongli Chen, Chao Liang
    Molecular Biomedicine.2024;[Epub]     CrossRef
  • Perianal fistulizing lesions of Crohn’s disease are associated with long-term behavior and its transition: a Chinese cohort study
    Wei Zhan, Xiaoyin Bai, Hong Yang, Jiaming Qian
    Intestinal Research.2024; 22(4): 484.     CrossRef
  • The Effects of Mannyeon-hwan on Acetic Acid-induced Ulcerative Colitis in Rats
    Won-ho Kong, Bum-hoi Kim, Won-ill Kim
    The Journal of Internal Korean Medicine.2024; 45(4): 681.     CrossRef
  • Unlocking the Power of Physical Activity in Inflammatory Bowel Disease: A Comprehensive Review
    Jiajia Chen, Shaopeng Sun, Andrew S. Day
    Gastroenterology Research and Practice.2024;[Epub]     CrossRef
  • Treatment Response and Safety of Herbal Medicine Combined with a Low-Carbohydrate Diet for Weight Reduction in Patients with Inflammatory Bowel Disease: A Retrospective Multicenter Study
    Ji-young Son, Su-yong Shin, Jung-sang Kim, Min-whee Kang, Dong-hun Lee, Seong-hyeon Jeon, Jun-ho Kim, Chung-hee Kim, Byung-soo Kang, Min-woo Bang
    The Journal of Internal Korean Medicine.2024; 45(6): 1136.     CrossRef
  • Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
    Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, Shinichiro Shinzaki, Noritaka Takatsu, Toshimitsu Fujii, Ryuichi Okamoto, Katsuyoshi Matsuoka, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Hisashi Shiga, Shigeki Bamba, Yohei Mikami, Takahiro Shimoya
    Journal of Crohn's and Colitis.2023; 17(8): 1193.     CrossRef
  • Alleviative mechanism and effect of Bifidobacterium animalisA6 on dextran sodium sulfate‐induced ulcerative colitis in mice
    Fang Wu, Guna Wuri, Bing Fang, Mengxuan Shi, Ming Zhang, Liang Zhao
    Food Science & Nutrition.2023; 11(2): 892.     CrossRef
  • A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
    Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
    Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
  • Safety and Effectiveness of Ustekinumab for Crohn’s Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed
    Katsumasa Nagano, Erina Hata, Teita Asano, Hiroaki Tsuchiya, Masayuki Takagishi, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
    Crohn's & Colitis 360.2023;[Epub]     CrossRef
  • Risk factors for poor sleep quality in patients with inflammatory bowel disease in China: A multicenter study
    Suqi Zeng, Chuan Liu, Jixiang Zhang, Ping An, Zhongchun Liu, Changqing Jiang, Jie Shi, Kaichun Wu, Weiguo Dong
    Frontiers in Psychiatry.2023;[Epub]     CrossRef
  • Comparison of the Persistence of Anti-TNF Agents and Ustekinumab in Patients with Crohn’s Disease: A Study Based on the Korean National Database
    Gi Hyeon Seo, Sung Hoon Jung
    Journal of Clinical Medicine.2023; 12(6): 2397.     CrossRef
  • A review article of inflammatory bowel disease treatment and pharmacogenomics
    Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem
    Beni-Suef University Journal of Basic and Applied Sciences.2023;[Epub]     CrossRef
  • Longitudinal trends in direct costs and healthcare utilization ascribable to inflammatory bowel disease in the biologic era: a nationwide, population‐based study
    Eun Young Park, Dong Hoon Baek, Gwang Ha Kim, Choongrak Kim, Hasung Kim, Jeong Woo Lee, Geun Am Song
    Journal of Gastroenterology and Hepatology.2023; 38(9): 1485.     CrossRef
  • Mucosal immune systems of pediatric inflammatory bowel disease: A review
    Takahiro Kudo, Toshiaki Shimizu
    Pediatrics International.2023;[Epub]     CrossRef
  • Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea
    Jin Woo Kim, Hyun Joo Song, Sun-Jin Boo, Heung Up Kim, Ki Soo Kang, Soo-Young Na
    The Korean Journal of Gastroenterology.2023; 81(6): 243.     CrossRef
  • A web-based survey on self-management for patients with inflammatory bowel disease in Japan
    Masakazu Nagahori, Takahito Imai, Mikiko Nakashoji, Ai Tairaka, Jovelle L. Fernandez, Pei-Yuan Su
    PLOS ONE.2023; 18(7): e0287618.     CrossRef
  • Vagus Nerve Stimulation Through Electro-acupuncture for Inflammatory Bowel Disease
    Minjeong Kim, Dongwon Kim, Chaehyun Park, Jae-Woo Park, Seok-Jae Ko
    The Journal of Internal Korean Medicine.2023; 44(3): 455.     CrossRef
  • Diagnosis of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
    Han Hee Lee, Jae Jun Park, Bo-In Lee, Ida Hilmi, Jose Sollano, Zhi Hua Ran
    Intestinal Research.2023; 21(3): 328.     CrossRef
  • Magnolia officinalis bark extract improves depressive-like behavior in DSS-induced colitis mice
    Min-Soo Kim, Jungim Kim, Kang-In Lee, Hye Jin Kim, Hyungjun Kim, Donghwan Kim, Ki-Sun Park
    Journal of Functional Foods.2023; 108: 105775.     CrossRef
  • Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan
    Fumihito Hirai, Akihito Uda, Mihoko Ota, Yukiko Takemura, Keisuke Tanaka, Ryuichi Iwakiri
    Digestion.2023; 104(2): 109.     CrossRef
  • IBD barriers across the continents – East Asia
    Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
    Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
  • Lycium barbarum polysaccharide alleviates DSS-induced chronic ulcerative colitis by restoring intestinal barrier function and modulating gut microbiota
    Zhi-Yu Li, Lan-Hui Lin, He-Jun Liang, Ya-Qi Li, Fu-Qian Zhao, Ting-Yi Sun, Zi-Yu Liu, Jing-Yi Zhu, Feng Gu, Jia-Ning Xu, Qi-Yuan Hao, De-Shan Zhou, Hui-Hong Zhai
    Annals of Medicine.2023;[Epub]     CrossRef
  • Geographical heterogeneity in the disease characteristics and management of patients with inflammatory bowel disease, the preliminary results of a Chinese database for IBD (CHASE-IBD)
    Jian Wan, Jun Shen, Xiaoping Wu, Jie Zhong, Yan Chen, Lanxiang Zhu, Yinglei Miao, Naizhong Hu, Jie Chen, Jie Liang, Kaichun Wu
    Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
  • Vaccination strategies for Korean patients with inflammatory bowel disease
    Yoo Jin Lee, Eun Soo Kim
    The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
  • Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index—A Report from the ImageKids Study
    Sapir Choshen, Dan Turner, Li-Tal Pratt, Ronit Precel, Mary-Louise Greer, Denise A Castro, Amit Assa, María I Martínez-León, Izabela Herman-Sucharska, Eva Coppenrath, Osnat Konen, Jorge Davila, Elhamy Bekhit, Zehour Alsabban, Gili Focht, Matan Gavish, Ann
    Inflammatory Bowel Diseases.2022; 28(5): 700.     CrossRef
  • Beneficial effect of capsaicin via TRPV4/EDH signals on mesenteric arterioles of normal and colitis mice
    Luyun Zhang, Wei Lu, Cheng Lu, Yanjun Guo, Xiongying Chen, Jun Chen, Feng Xu, Hanxing Wan, Hui Dong
    Journal of Advanced Research.2022; 39: 291.     CrossRef
  • The Involvement of Glial Cell-Derived Neurotrophic Factor in Inflammatory Bowel Disease
    HuiLing Chen, TiYun Han, LiPing Gao, DeKui Zhang
    Journal of Interferon & Cytokine Research.2022; 42(1): 1.     CrossRef
  • Active and passive smoking and risk of ulcerative colitis: A case–control study in Japan
    Atsushi Nishikawa, Keiko Tanaka, Yoshihiro Miyake, Chisato Nagata, Shinya Furukawa, Akira Andoh, Tetsuji Yokoyama, Naoki Yoshimura, Kenichiro Mori, Tomoyuki Ninomiya, Yasunori Yamamoto, Eiji Takeshita, Yoshio Ikeda, Mitsuru Saito, Katsuhisa Ohashi, Hirots
    Journal of Gastroenterology and Hepatology.2022; 37(4): 653.     CrossRef
  • Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohn's Disease Receiving Anti-TNF Therapy
    Kyunghwan Oh, Eun Hye Oh, Soo Min Noh, Seong Ho Park, Nayoung Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
    Clinical and Translational Gastroenterology.2022; 13(1): e00442.     CrossRef
  • Clinical Characteristics of Crohn's Disease in a Cohort from Saudi Arabia
    Yousef A. Qari
    Saudi Journal of Medicine & Medical Sciences.2022; 10(1): 56.     CrossRef
  • Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data
    Seo-Hee Kim, Yujin Park, Seong Pyo Kim, Sung Hee Lee, Seak Hee Oh, Suk-Kyun Yang, Hyung-Jin Yoon, Kyung Mo Kim
    Digestive Diseases and Sciences.2022; 67(11): 5079.     CrossRef
  • Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
    Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Y
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Screening and Evaluation of Probiotics for Reducing Intestinal Inflammation
    雅君 陈
    Hans Journal of Food and Nutrition Science.2022; 11(01): 44.     CrossRef
  • Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab
    Rosanne Ottevanger, Rutger C. Melchers, Koen D. Quint
    JAAD Case Reports.2022; 22: 34.     CrossRef
  • Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update
    Shanmugaprakasham Selvamani, Vijay Mehta, Hesham Ali El Enshasy, Suganthi Thevarajoo, Hala El Adawi, Ibrahim Zeini, Khoa Pham, Theodoros Varzakas, Bassam Abomoelak
    Saudi Journal of Biological Sciences.2022; 29(5): 3546.     CrossRef
  • Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South‐East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease‐Emerging Nations' Consortium
    Rupa Banerjee, Partha Pal, Ida Hilmi, Uday C Ghoshal, Devendra C Desai, Mohammed Masudur Rahman, Usha Dutta, Syed A Mohiuddin, Munnera Al Mohannadi, Mathew Philip, Ganesh N Ramesh, Madunil A Niriella, Arjuna P De Silva, Hithanadura Janaka de Silva, Pises
    Journal of Gastroenterology and Hepatology.2022; 37(6): 1004.     CrossRef
  • Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study
    Byong Duk Ye, Sung Noh Hong, Seung In Seo, Ye-Jee Kim, Jae Myung Cha, Kyoung Hoon Rhee, Hyuk Yoon, Young-Ho Kim, Kyung Ho Kim, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim,
    Gut and Liver.2022; 16(2): 216.     CrossRef
  • Capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption by blocking TRPV4 channels in healthy and colitic mice
    Hanxing Wan, Xiong Ying Chen, Fenglian Zhang, Jun Chen, Fenglan Chu, Zachary M. Sellers, Feng Xu, Hui Dong
    Journal of Biological Chemistry.2022; 298(5): 101847.     CrossRef
  • Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
    Ji Min Lee, Shu-Chen Wei, Kang-Moon Lee, Byong Duk Ye, Ren Mao, Hyun-Soo Kim, Soo Jung Park, Sang Hyoung Park, Eun Hye Oh, Jong Pil Im, Byung Ik Jang, Dae Bum Kim, Ken Takeuchi
    Gut and Liver.2022; 16(3): 396.     CrossRef
  • The Effect of Empowering Education Combined With Mindfulness Meditation Training on Negative Emotion and Quality of Life in Patients With Inflammatory Bowel Disease
    Wei-Zhen Xi, Chong-Wu Xu, Ling-Ling Wang
    Frontiers in Behavioral Neuroscience.2022;[Epub]     CrossRef
  • The first association study of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2) gene polymorphisms in Malaysian patients with Crohn’s disease
    Xiang Ting Goh, Suh Kuan Fong, Hwa Chia Chai, Boon Pin Kee, Kek Heng Chua
    Gene.2022; 836: 146661.     CrossRef
  • The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
    Xinwei Xu, Dickson Kofi Wiredu Ocansey, Sanhua Hang, Bo Wang, Samuel Amoah, Chengxue Yi, Xu Zhang, Lianqin Liu, Fei Mao
    Gut Pathogens.2022;[Epub]     CrossRef
  • Differences in MUC2 Gene Expression Based on the Clinical Severity of Colitis and the Degree of Histopathological Damage to the Colonic Mucosa in Colitis-induced Rat
    Saptino Miro, Arni Amir, Nasrul Zubir, Andani Eka Putra
    Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 1170.     CrossRef
  • Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016
    Hong Yang, Runing Zhou, Xiaoyin Bai, Mingyue Guo, Gechong Ruan, Li Wang, Jiaming Qian
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Mechanism of electroacupuncture and herb-partitioned moxibustion on ulcerative colitis animal model: A study based on proteomics
    Qin Qi, Rui Zhong, Ya-Nan Liu, Chen Zhao, Yan Huang, Yuan Lu, Zhe Ma, Han-Dan Zheng, Lu-Yi Wu
    World Journal of Gastroenterology.2022; 28(28): 3644.     CrossRef
  • Evaluating macro‐ and micronutrients and food groups intake with the risk of developing inflammatory bowel disease: Is there any association?
    Farnaz Farsi, Negin Tahvilian, Azadeh Heydarian, Sara Karimi, Sara Ebrahimi, Nasser Ebrahimi‐Daryani, Sanam Tabataba‐Vakili, Javad Heshmati, Marjan Mokhtare
    Food Science & Nutrition.2022; 10(11): 3920.     CrossRef
  • Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
    Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, Hyun Mi Lee, Won Eui Yoon, Seo Hyun Kim, Hee Jun Myung, Jeong Seop Moon
    Intestinal Research.2022; 20(3): 321.     CrossRef
  • Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
    Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang-Moon Lee, Ji Won Kim, Sung-Ae Jung, Jun Lee, Sang-Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun-Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young-Ho Ki
    Intestinal Research.2022; 20(3): 350.     CrossRef
  • Landscape of inflammatory bowel disease in Singapore
    Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi
    Intestinal Research.2022; 20(3): 291.     CrossRef
  • Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
    Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Kenji Watanabe, Hisashi Shiga, Noritaka Takatsu, Shigeki Bamba, Yohei Mikami, Takayuki Yamamoto, Takahiro Shimoyama, Satoshi Motoya, Takehiro Torisu,
    Journal of Gastroenterology.2022; 57(11): 867.     CrossRef
  • Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case—Control Study
    Kyung Jae Lee, So Yoon Choi, Yoo Min Lee, Han Wool Kim
    Vaccines.2022; 10(8): 1265.     CrossRef
  • Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019
    Yang Zhang, Jiali Liu, Xiao Han, Hui Jiang, Liming Zhang, Juncong Hu, Lei Shi, Junxiang Li
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?
    Su Bee Park, Jin Young Yoon, Jae Myung Cha
    Gut and Liver.2022; 16(5): 676.     CrossRef
  • Pilot study of an elimination diet in adults with mild to moderate Crohn’s disease
    Neeraj Narula, Emily C.L. Wong, Paul Moayyedi, Walter Reinisch, John K. Marshall
    European Journal of Gastroenterology & Hepatology.2022; 34(12): 1210.     CrossRef
  • Natural history of inflammatory bowel disease: a comparison between the East and the West
    Eun Mi Song, Suk-Kyun Yang
    Intestinal Research.2022; 20(4): 418.     CrossRef
  • Treatment with Extracellular Vesicles from Giardia lamblia Alleviates Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice
    Hyun Jung Kim, Young-Ju Lee, Seon-Ok Back, Shin-Hyeong Cho, Hee-Il Lee, Myoung-Ro Lee
    The Korean Journal of Parasitology.2022; 60(5): 309.     CrossRef
  • Uptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease
    Shinji Ota, Hirotake Sakuraba
    Immuno.2022; 2(4): 692.     CrossRef
  • Long-Term Trends in the Burden of Inflammatory Bowel Disease in China Over Three Decades: A Joinpoint Regression and Age-Period-Cohort Analysis Based on GBD 2019
    Yang Zhang, Jiali Liu, Xiao Han, Hui Jiang, Liming Zhang, Juncong Hu, Lei Shi, Junxiang Li
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Differences in inflammatory bowel diseases between East and West: a Chinese perspective
    Guanglin Cui, Junling Li, Hanzhe Liu, Jann-Birger Laugsand, Zhanju Liu
    Journal of Public Health.2021; 29(1): 19.     CrossRef
  • Structural and functional changes in the brain of patients with Crohn’s disease: an activation likelihood estimation meta-analysis
    Andy Wai Kan Yeung
    Brain Imaging and Behavior.2021; 15(2): 807.     CrossRef
  • Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
    Zhihua Ran, Kaichun Wu, Katsuyoshi Matsuoka, Yoon Tae Jeen, Shu Chen Wei, Vineet Ahuja, Minhu Chen, Pin‐Jin Hu, Akira Andoh, Hyo Jong Kim, Suk‐Kyun Yang, Mamoru Watanabe, Siew Chien Ng, Toshifumi Hibi, Ida Normiha Hilmi, Yasuo Suzuki, Dong Soo Han, Wai Ke
    Journal of Gastroenterology and Hepatology.2021; 36(3): 637.     CrossRef
  • Exclusive enteral nutrition is effective and feasible as primary induction and re‐induction therapy in Asian children with Crohn's disease
    Kok Joo Chan, Zhi Liang Song, Kee Seang Chew, Ruey Terng Ng, Siti Hawa Mohd Taib, Way Seah Lee
    Journal of Paediatrics and Child Health.2021; 57(2): 239.     CrossRef
  • The four epidemiological stages in the global evolution of inflammatory bowel disease
    Gilaad G. Kaplan, Joseph W. Windsor
    Nature Reviews Gastroenterology & Hepatology.2021; 18(1): 56.     CrossRef
  • Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles?
    Mostafa Vaghari-Tabari, Davoud Jafari-Gharabaghlou, Fatemeh Sadeghsoltani, Parisa Hassanpour, Durdi Qujeq, Nadereh Rashtchizadeh, Amir Ghorbanihaghjo
    Biological Trace Element Research.2021; 199(9): 3190.     CrossRef
  • Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
    Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
    Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
  • Mycosis fungoides in a patient with ulcerative colitis on anti-tumor necrosis factor-alpha therapy
    Takeshi Yasuda, Tomohisa Takagi, Jun Asai, Norito Katoh, Junya Kuroda, Yasumichi Kuwahara, Yukiko Morinaga, Eiichi Konishi, Kazuhiko Uchiyama, Yuji Naito, Yoshito Itoh
    Clinical Journal of Gastroenterology.2021; 14(1): 170.     CrossRef
  • The Response of the Tongue Epithelial on Cigarette Smoke Exposure as a Risk Factor for Oral Cancer Development
    Neken Prasetyaningtyas, Nabilah Azzahra Jatiatmaja, Desiana Radithia, Hening Tuti Hendarti, Adiastuti Endah Parmadiati, Priyo Hadi, Fatma Yasmin Mahdani, Diah Savitri Ernawati, Rosnah binti Zain, Nurina Febriyanti Ayuningtyas
    European Journal of Dentistry.2021; 15(02): 320.     CrossRef
  • Racial disparities exist in surgical outcomes for patients with inflammatory bowel disease
    Isabel C. Dos Santos Marques, Lauren M. Theiss, Lauren N. Wood, Drew J. Gunnells, Robert H. Hollis, Karin M. Hardiman, Jamie A. Cannon, Melanie S. Morris, Gregory D. Kennedy, Daniel I. Chu
    The American Journal of Surgery.2021; 221(4): 668.     CrossRef
  • Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice
    Yoo Min Han, Jaemoon Koh, Jee Hyun Kim, Jooyoung Lee, Jong Pil Im, Joo Sung Kim
    Gut and Liver.2021; 15(1): 100.     CrossRef
  • Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
    Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
    Gut and Liver.2021; 15(1): 92.     CrossRef
  • Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study
    Jeongseok Kim, Hyuk Yoon, Nayoung Kim, Kang-Moon Lee, Sung-Ae Jung, Chang Hwan Choi, Eun Soo Kim, Yunho Jung, Chang Soo Eun, Tae Oh Kim, Sang-Bum Kang, You Sun Kim, Geom-Seog Seo, Chang Kyun Lee, Jong Pil Im, Soo Jung Park, Dong Il Park, Byong Duk Ye
    Inflammatory Bowel Diseases.2021; 27(12): 1931.     CrossRef
  • Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
    Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel
    Intestinal Research.2021; 19(1): 53.     CrossRef
  • Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
    Yutaro Soejima, Yohei Kirino, Mitsuhiro Takeno, Michiko Kurosawa, Masaki Takeuchi, Ryusuke Yoshimi, Yumiko Sugiyama, Shigeru Ohno, Yukiko Asami, Akiko Sekiguchi, Toshihisa Igarashi, Shohei Nagaoka, Yoshiaki Ishigatsubo, Hideaki Nakajima, Nobuhisa Mizuki
    Arthritis Research & Therapy.2021;[Epub]     CrossRef
  • Differential effects of EPA and DHA on DSS-induced colitis in mice and possible mechanisms involved
    Zhuangwei Zhang, Zhe Xue, Haitao Yang, Feng Zhao, Chundi Liu, Jiahui Chen, Songtao Lu, Zuquan Zou, Yuping Zhou, Xiaohong Zhang
    Food & Function.2021; 12(4): 1803.     CrossRef
  • Proteinuria Is Associated with the Development of Crohn’s Disease: A Nationwide Population-Based Study
    Seona Park, Hyun Jung Lee, Kyung-Do Han, Hosim Soh, Jung Min Moon, Seung Wook Hong, Eun Ae Kang, Jong Pil Im, Joo Sung Kim
    Journal of Clinical Medicine.2021; 10(4): 799.     CrossRef
  • Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood
    Ge Jin, Qiang Tang, Jiaheng Ma, Xiang Liu, Bingqian Zhou, Yue Sun, Xiaoqi Pang, Zixuan Guo, Runxiang Xie, Tianyu Liu, Bangmao Wang, Hailong Cao, Hongwei Zhou
    mSystems.2021;[Epub]     CrossRef
  • Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats
    Ping Wang, Yan Chen, La-Mei Zhang, Si-Qi Yuan, Shen-Ao Lu, Ying-Jian Zhang
    Life Sciences.2021; 278: 119603.     CrossRef
  • Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study
    Neeraj Narula, Emily C L Wong, Mahshid Dehghan, Andrew Mente, Sumathy Rangarajan, Fernando Lanas, Patricio Lopez-Jaramillo, Priyanka Rohatgi, P V M Lakshmi, Ravi Prasad Varma, Andres Orlandini, Alvaro Avezum, Andreas Wielgosz, Paul Poirier, Majid A Almadi
    BMJ.2021; : n1554.     CrossRef
  • Evaluation of economic burden with biologic treatments in Crohn’s disease patients: A mirror image study using an insurance database in Japan
    Celine Miyazaki, Nagano Katsumasa, Kuan Chih Huang, Yan Fang Liu, Kevin Lu
    PLOS ONE.2021; 16(7): e0254807.     CrossRef
  • Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post‐marketing surveillance in Japan
    Seiji Yokoyama, Teita Asano, Katsumasa Nagano, Hiroaki Tsuchiya, Masayuki Takagishi, Shigeharu Tsujioka, Naomi Miura, Takayuki Matsumoto
    Journal of Gastroenterology and Hepatology.2021; 36(11): 3069.     CrossRef
  • Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
    Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee
    Intestinal Research.2021; 19(3): 323.     CrossRef
  • Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
    Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
    Medicine.2021; 100(34): e27065.     CrossRef
  • Epidemiology and diagnosis of inflammatory bowel diseases
    Kang-Moon Lee
    Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
  • MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2
    Siwen Tang, Wentao Guo, Liumin Kang, Jinghua Liang
    Journal of Molecular Histology.2021; 52(6): 1215.     CrossRef
  • Incident Crohn’s Disease as a Risk Factor for Colorectal Cancer in the First 10 Years after Diagnosis: A Nationwide Population-Based Study
    Hyunil Kim, Ji Hoon Kim, Jung Kuk Lee, Dae Ryong Kang, Su Young Kim, Hyun-Soo Kim, Hee Man Kim
    Journal of Clinical Medicine.2021; 10(20): 4663.     CrossRef
  • Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
    Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, Bella Ungar, Shelly Soffer, Marianne M. Amitai, Eyal Klang, Uri Kopylov
    Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
  • Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
    Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi
    Intestinal Research.2021; 19(4): 408.     CrossRef
  • Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
    Guanglin Cui, Hanzhe Liu, Gang Xu, Jann-Birger Laugsand, Zhigang Pang
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
    Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano
    Intestinal Research.2021; 19(4): 386.     CrossRef
  • Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
    Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
    Intestinal Research.2021; 19(4): 419.     CrossRef
  • Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study
    Ju-Young Shin, Hye-Min Park, Min-Young Lee, Ja-Young Jeon, Hyun-Jeong Yoo, Byong Duk Ye
    Gut and Liver.2021; 15(6): 867.     CrossRef
  • Clinical Remission of Crohn’s Disease Induced by Herbal Decoction (Jinmoo-tang): A Case Report
    Byunghee Lee, Jiyoon Won, Hyangsook Lee
    Journal of Physiology & Pathology in Korean Medicine.2021; 35(6): 255.     CrossRef
  • Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease
    Kwangwoo Nam, Sang Hyoung Park, Junghwan Lee, Seokjung Jo, Seon‐Ok Kim, Soomin Noh, Jae Cheol Park, Jin Yong Kim, Jeongseok Kim, Nam Seok Ham, Eun Hye Oh, Eun Mi Song, Sung Wook Hwang, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Ky
    Journal of Gastroenterology and Hepatology.2020; 35(2): 218.     CrossRef
  • Potential influential factors on incidence and prevalence of inflammatory bowel disease in mainland China
    Yuqi Qiao, Zhihua Ran
    JGH Open.2020; 4(1): 11.     CrossRef
  • Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
    Luis Hernandez, Hiroyo Kuwabara, Anshul Shah, Kaoru Yamabe, Heather Burnett, Kyle Fahrbach, Maria Koufopoulou, Ryuichi Iwakiri
    PharmacoEconomics.2020; 38(1): 69.     CrossRef
  • Nutritional and dietary strategy in the clinical care of inflammatory bowel disease
    Meng-Shu Hsieh, Wen-Hung Hsu, Jiunn-Wei Wang, Yao-Kuang Wang, Huang-Ming Hu, Wei-Kuo Chang, Chih-Yen Chen, Deng-Chyang Wu, Fu-Chen Kuo, Wei-Wen Su
    Journal of the Formosan Medical Association.2020; 119(12): 1742.     CrossRef
  • UK Patients of Bangladeshi Descent with Crohn’s Disease Respond Less Well to TNF Antagonists Than Caucasian Patients
    Radha Gadhok, Hannah Gordon, Gregory Sebepos-Rogers, Samantha Baillie, Saniath Akbar, Jane E. Abbott, Emma Michael, Omer F. Ahmad, Ben Cooper, James O. Lindsay
    Digestive Diseases and Sciences.2020; 65(6): 1790.     CrossRef
  • Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
    Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
    Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
  • Intestinal Epithelial Deletion of Sphk1 Prevents Colitis-Associated Cancer Development by Inhibition of Epithelial STAT3 Activation
    Seung Bin Park, Byung-il Choi, Beom Jae Lee, Nam Joo Kim, Yoon A. Jeong, Moon Kyung Joo, Hyo Jung Kim, Jong-Jae Park, Jae Seon Kim, Yoon-Seok Noh, Hyun Joo Lee
    Digestive Diseases and Sciences.2020; 65(8): 2284.     CrossRef
  • High-fat diet-derived free fatty acids impair the intestinal immune system and increase sensitivity to intestinal epithelial damage
    Shohei Tanaka, Yasuhiro Nemoto, Yuria Takei, Ryo Morikawa, Shigeru Oshima, Takashi Nagaishi, Ryuichi Okamoto, Kiichiro Tsuchiya, Tetsuya Nakamura, Susanne Stutte, Mamoru Watanabe
    Biochemical and Biophysical Research Communications.2020; 522(4): 971.     CrossRef
  • Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses
    Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi
    Journal of Gastroenterology.2020; 55(3): 291.     CrossRef
  • Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classification
    Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli
    European Journal of Gastroenterology & Hepatology.2020; 32(2): 187.     CrossRef
  • Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
    Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
    Yonsei Medical Journal.2020; 61(1): 48.     CrossRef
  • Nicotine-induced autophagy via AMPK/mTOR pathway exerts protective effect in colitis mouse model
    Qian Gao, Pinduan Bi, Ding Luo, Ying Guan, Wanli Zeng, Haiying Xiang, Qili Mi, Guangyu Yang, Xuemei Li, Bin Yang
    Chemico-Biological Interactions.2020; 317: 108943.     CrossRef
  • Emerging Involvement of long non-coding RNAs in gastrointestinal associated inflammatory disorders
    Hamed Esmaeil Lashgarian, Maryam Karkhane, Abdolrazagh Marzban, Mohammad Yazdi, Kiana Shahzamani
    Comparative Immunology, Microbiology and Infectious Diseases.2020; 69: 101428.     CrossRef
  • Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study
    Jooyoung Lee, Jong Pil Im, Kyungdo Han, Jihye Kim, Hyun Jung Lee, Jaeyoung Chun, Joo Sung Kim
    Gut and Liver.2020; 14(1): 89.     CrossRef
  • Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
    Yoon Suk Jung
    Gut and Liver.2020; 14(1): 3.     CrossRef
  • Role of microRNA-449a in the progress of inflammatory bowel disease in children
    Dandan Zhao, Na Wu, Libo Wang, Xiaoli Pang, Xuehua Liu, Xiaohong Zhang
    Biotechnology & Biotechnological Equipment.2020; 34(1): 144.     CrossRef
  • Lovastatin derivative dehydrolovastatin ameliorates ulcerative colitis in mice by suppressing NF-κB and inflammatory cytokine expression
    Xu Zhang, Qing-Hua Deng, Jian-Hua Deng, Sheng-Ju Wang, Qiu Chen
    The Korean Journal of Physiology & Pharmacology.2020; 24(2): 137.     CrossRef
  • Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling
    Akihito Uda, Yuki Eto, Yuxin Li, Hiroyuki Matsuda, Sven Demiya, Tomoyuki Watanabe, Mihoko Ota, Ryuichi Iwakiri, Ataru Igarashi
    Crohn's & Colitis 360.2020;[Epub]     CrossRef
  • Effect of Berberine from Coptis chinensis on Apoptosis of Intestinal Epithelial Cells in a Mouse Model of Ulcerative Colitis: Role of Endoplasmic Reticulum Stress
    Shen Yan, Liu Yingchao, Wang Zhangliu, Ruan Xianli, Li Si, Ni Siyi, Zhong Jihong, Sokcheon Pak
    Evidence-Based Complementary and Alternative Medicine.2020;[Epub]     CrossRef
  • Ethanol extract of Pycnoporus sanguineus relieves the dextran sulfate sodium-induced experimental colitis by suppressing helper T cell-mediated inflammation via apoptosis induction
    Xiaohong Chen, Muxia Li, Dan Li, Ting Luo, Yizhen Xie, Liang Gao, Yifan Zhang, Shaodan Chen, Shunxian Li, Guoxin Huang, Wenzhi Li, Jiyan Su, Xiaoping Lai
    Biomedicine & Pharmacotherapy.2020; 127: 110212.     CrossRef
  • Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review
    Ming Han Cha, Miguel Regueiro, Dalbir S Sandhu
    World Journal of Gastroenterology.2020; 26(19): 2323.     CrossRef
  • Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study
    Xiaolong Ge, Huaying Liu, Shasha Tang, Yan Wu, Yipeng Pan, Wei Liu, Weilin Qi, Lingna Ye, Qian Cao, Wei Zhou
    International Journal of Surgery.2020; 79: 294.     CrossRef
  • Patterns of Ulcerative Colitis Treatments and Factors Affecting the Prescribing of Systemic Corticosteroid using Health Insurance Claims Database
    Jiyool Kim, So-Hee Park, Ju-Young Shin
    Korean Journal of Clinical Pharmacy.2020; 30(2): 102.     CrossRef
  • Polysaccharide isolated from Auricularia auricular‐judae (Bull.) prevents dextran sulfate sodium‐induced colitis in mice through modulating the composition of the gut microbiota
    Di Zhao, Wenjing Dai, Heng Tao, Wei Zhuang, Mi Qu, Ya‐Ning Chang
    Journal of Food Science.2020; 85(9): 2943.     CrossRef
  • Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country
    Mortada HF El-Shabrawi, Sara Tarek, Maha Abou-Zekri, Safa Meshaal, Afaf Enayet, Engy Adel Mogahed
    World Journal of Gastrointestinal Pharmacology and Therapeutics.2020; 11(3): 48.     CrossRef
  • Is the rise in Crohn’s disease in India accompanied by a fall in intestinal tuberculosis? A single-center experience
    Pavan Dhoble, Devendra Desai, Philip Abraham
    Indian Journal of Tuberculosis.2020;[Epub]     CrossRef
  • Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
    Pabitra Sahu, Sudheer K. Vuyyuru, Bhaskar Kante, Ashish Agarwal, Raju Sharma, Prasenjit Das, Rajesh Panwar, Saransh Jain, Sawan Bopanna, Govind Makharia, Saurabh Kedia, Vineet Ahuja
    Indian Journal of Gastroenterology.2020; 39(4): 388.     CrossRef
  • The effect of miRNA and autophagy on colorectal cancer
    Jiali Long, Qinglian He, Yuting Yin, Xue Lei, Ziqi Li, Wei Zhu
    Cell Proliferation.2020;[Epub]     CrossRef
  • Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study
    Eun Ae Kang, Jaeyoung Chun, Jee Hyun Kim, Kyungdo Han, Hosim Soh, Seona Park, Seung Wook Hong, Jung Min Moon, Jooyoung Lee, Hyun Jung Lee, Jun-Beom Park, Jong Pil Im, Joo Sung Kim
    World Journal of Gastroenterology.2020; 26(37): 5661.     CrossRef
  • An assessment of dietary intake, food avoidance and food beliefs in patients with ulcerative colitis of different disease status
    Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, Raja Affendi Raja Ali
    Intestinal Research.2020; 18(4): 447.     CrossRef
  • Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
    Kenji Watanabe
    Intestinal Research.2020; 18(4): 347.     CrossRef
  • Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study
    Hussein Mahajna, Yiftach Barash, Bella Ungar, Shelly Soffer, Ahmad Albshesh, Asaf Levartovsky, Shomron Ben-Horin, Eyal Klang, Uri Kopylov
    Journal of Clinical Medicine.2020; 9(11): 3651.     CrossRef
  • Preconception Care Program for Women with Inflammatory Bowel Disease Using Intervention Mapping: A Protocol for Program Development
    Young Jin Lee, Yeon Hee Kim, Hae Won Kim
    International Journal of Environmental Research and Public Health.2020; 17(24): 9365.     CrossRef
  • Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice
    Seong-Joon Koh, Youn-I Choi, Yuri Kim, Yoo-Sun Kim, Sang Woon Choi, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee
    European Journal of Nutrition.2019; 58(4): 1603.     CrossRef
  • Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
    Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
    Intestinal Research.2019; 17(1): 54.     CrossRef
  • 5‐Hydroxytryptamine (5‐HT)‐exacerbated DSS‐induced colitis is associated with elevated NADPH oxidase expression in the colon
    Shizhen Dong, Menglu Chen, Faliang Dai, Qingxia Xuan, Pan Chen, Dandan Feng, Lei Gao, Chendi Zhu, Yongchao Chang, Fong‐Fong Chu, Qiang Gao
    Journal of Cellular Biochemistry.2019; 120(6): 9230.     CrossRef
  • Emerging trends of inflammatory bowel disease in South Korea: A nationwide population‐based study
    Min Seob Kwak, Jae Myung Cha, Hun Hee Lee, Yong Sung Choi, Seung In Seo, Kyung Jin Ko, Dong Il Park, Sung Hun Kim, Tae Jun Kim
    Journal of Gastroenterology and Hepatology.2019; 34(6): 1018.     CrossRef
  • Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease
    Kyoung Ho Ko, You Sun Kim, Bo Kyung Lee, Jong Hyun Choi, Yong Moon Woo, Jin Young Kim, Jeong Seop Moon
    Intestinal Research.2019; 17(1): 70.     CrossRef
  • Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study
    Seung Kim, Sowon Park, Yunkoo Kang, Jung Eun Kim, Ben Kang, Byung‐Ho Choe, Yeoun Joo Lee, Jae Hong Park, Hye Ran Yang, Sung Hee Lee, Kyung Mo Kim, Eell Ryoo, Hann Tchah, Jung Ok Shim, Hong Koh
    Journal of Pediatric Gastroenterology and Nutrition.2019; 68(1): 45.     CrossRef
  • Detection and management of early stage inflammatory bowel disease: an update for clinicians
    Laura Loy, Giulia Roda, Gionata Fiorino, Mariangela Allocca, Federica Furfaro, Marjorie Argollo, Laurent Peyrin-Biroulet, Silvio Danese
    Expert Review of Gastroenterology & Hepatology.2019; 13(6): 547.     CrossRef
  • Anti-inflammatory effects of mulberry twig extracts on dextran sulfate sodium-induced colitis mouse model
    Xuelei Cui, Eunjung Kim
    Journal of Nutrition and Health.2019; 52(2): 139.     CrossRef
  • A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986–2015
    Sang Hyoung Park, Ye-Jee Kim, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan K
    Journal of Crohn's and Colitis.2019; 13(11): 1410.     CrossRef
  • Dose–response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study
    Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
    Journal of Gastroenterology.2019; 54(10): 881.     CrossRef
  • A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
    Eun Jin Jang, Jung Eun Ha, Seul Gi Im, Myeong Gyu Kim, Hyun Soon Sohn
    Clinical Drug Investigation.2019; 39(7): 625.     CrossRef
  • Exposure of the Host-Associated Microbiome to Nutrient-Rich Conditions May Lead to Dysbiosis and Disease Development—an Evolutionary Perspective
    Tim Lachnit, Thomas C. G. Bosch, Peter Deines, Margaret J. McFall-Ngai
    mBio.2019;[Epub]     CrossRef
  • Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia
    Rajesh Bhatia, Sern Wei Yeoh, Karl Vaz, Corrie Studd, Jarrad Wilson, Sally Bell, Petr Otahal, Alison Venn
    Internal Medicine Journal.2019; 49(5): 622.     CrossRef
  • Crohn’s Disease: Potential Drugs for Modulation of Autophagy
    Nursyuhada Azzman
    Medicina.2019; 55(6): 224.     CrossRef
  • Systematic review with meta‐analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease
    Adam Tepler, Neeraj Narula, Richard M. Peek, Anish Patel, Cyrus Edelson, Jean‐Frederic Colombel, Shailja C. Shah
    Alimentary Pharmacology & Therapeutics.2019; 50(2): 121.     CrossRef
  • A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia
    Norfilza Mohd Mokhtar, Khairul Najmi Muhammad Nawawi, Jaarvis Verasingam, Wong Zhiqin, Ismail Sagap, Zairul Azwan Mohd Azman, Luqman Mazlan, Hamzaini Abdul Hamid, Nur Yazmin Yaacob, Isa Mohamed Rose, Eden Low Ngah Den, Mah Suit Wan, Raja Affendi Raja Ali
    BMC Public Health.2019;[Epub]     CrossRef
  • Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
    You-Jung Choi, Eue-Keun Choi, Kyung-Do Han, Jiesuck Park, Inki Moon, Euijae Lee, Won-Seok Choe, So-Ryoung Lee, Myung-Jin Cha, Woo-Hyun Lim, Seil Oh
    World Journal of Gastroenterology.2019; 25(22): 2788.     CrossRef
  • Emotional dysfunction and inflammatory bowel disease
    Si-Hui Li, Qiao-Feng Wu
    World Chinese Journal of Digestology.2019; 27(12): 727.     CrossRef
  • Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014)
    Jung Eun Ha, Eun Jin Jang, Seul Gi Im, Hyun Soon Sohn
    Korean Journal of Clinical Pharmacy.2019; 29(2): 79.     CrossRef
  • Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis
    Nava Morshedzadeh, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Vahid Chaleshi, Azita Hekmatdoost, Soheila Karimi, Mohammad Reza Zali, Parvin Mirmiran
    Complementary Therapies in Medicine.2019; 46: 36.     CrossRef
  • Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study
    Yoon Jin Choi, Dong Ho Lee, Dong Woo Shin, Kyung‐Do Han, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim
    Alimentary Pharmacology & Therapeutics.2019; 50(7): 769.     CrossRef
  • Taraxacum officinale extract ameliorates dextran sodium sulphate‐induced colitis by regulating fatty acid degradation and microbial dysbiosis
    Wei Chen, Huining Fan, Rui Liang, Rui Zhang, Jing Zhang, Jinshui Zhu
    Journal of Cellular and Molecular Medicine.2019; 23(12): 8161.     CrossRef
  • Marked regional variations in the prevalence of inflammatory bowel disease in a limited geographical region are not associated with compounds in the drinking water
    Fredrik Segerman, Spencer Clarkson, Klas Sjöberg
    Scandinavian Journal of Gastroenterology.2019; 54(10): 1250.     CrossRef
  • Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome
    Simon Ghaly, Prue H. Hart, Ian C Lawrance
    Expert Review of Gastroenterology & Hepatology.2019; 13(11): 1039.     CrossRef
  • Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis
    Wanbin He, Chengjun Zheng, Yonghong Wang, Jie Dan, Mingjie Zhu, Mingtian Wei, Jian Wang, Ziqiang Wang
    European Journal of Gastroenterology & Hepatology.2019; 31(12): 1489.     CrossRef
  • Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
    Jooyoung Lee, Jong Pil Im, Kyungdo Han, Seona Park, Hosim Soh, Kukhwan Choi, Jihye Kim, Jaeyoung Chun, Joo Sung Kim
    World Journal of Gastroenterology.2019; 25(42): 6354.     CrossRef
  • Huang-Lian-Jie-Du Decoction Ameliorates Acute Ulcerative Colitis in Mice via Regulating NF-κB and Nrf2 Signaling Pathways and Enhancing Intestinal Barrier Function
    Ziwen Yuan, Lihong Yang, Xiaosong Zhang, Peng Ji, Yongli Hua, Yanming Wei
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients
    Qin Cao, Yu-Hong Huang, Min Jiang, Cong Dai
    Scandinavian Journal of Gastroenterology.2019; 54(12): 1458.     CrossRef
  • Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study
    Wei-Chen Lin, Meng-Tzu Weng, Chien-Chih Tung, Yuan-Ting Chang, Yew-Loong Leong, Yu-Ting Wang, Horng-Yuan Wang, Jau-Min Wong, Shu-Chen Wei
    Journal of Translational Medicine.2019;[Epub]     CrossRef
  • Knowledge and Viewpoints on Biosimilar Monoclonal Antibodies among Asian Physicians: Comparison with European Physicians
    Soo-Kyung Park, Won Moon, Eun Soo Kim, Sang Hyun Park, Dong Il Park
    The Korean Journal of Gastroenterology.2019; 74(6): 333.     CrossRef
  • BIOSAFETY OF THE FAR EAST REGION OF RUSSIA: EPIDEMIOLOGICAL AND EPIZOOTIC TRENDS
    Natalya A. Kuznetsova, B. G Andryukov
    Epidemiology and Infectious Diseases.2019; 24(3): 128.     CrossRef
  • Colonoscopic abnormalities in patients with IBD in a referral hospital in Salvador - Bahia
    Carlos Ramon Silveira Mendes, Taísa Maria Brito Amorim, Lana Ferreira Moreira, Rafaela Mendonça Leal, Adriana Conceição de Mello Andrade
    Gastroenterology & Hepatology: Open Access.2019;[Epub]     CrossRef
  • Switching off Inflammation with Diet: A Review of Exclusive Enteral Nutrition in Children with Crohn’s Disease
    Andrew S. Day
    EMJ Gastroenterology.2019; : 86.     CrossRef
  • The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease
    Shiyuan Wang, Yan Huang, Cili Zhou, Huangan Wu, Jimeng Zhao, Luyi Wu, Min Zhao, Fang Zhang, Huirong Liu
    Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
  • Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis
    Sedigheh Pouya, Maryam Heidari, Kaveh Baghaei, Hamid Asadzadeh Aghdaei, Afshin Moradi, Saeed Namaki, Mohammad Reza Zali, Seyed Mahmoud Hashemi
    International Immunopharmacology.2018; 54: 86.     CrossRef
  • Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study
    Suk Jin Hong, Seung Man Cho, Byung-Ho Choe, Hyo Jeong Jang, Kwang Hae Choi, Ben Kang, Jung Eun Kim, Jun Hyun Hwang
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease
    Guanglin Cui, Aping Yuan
    Frontiers in Medicine.2018;[Epub]     CrossRef
  • Herb-partitioned moxibustion alleviates colon injuries in ulcerative colitis rats
    Dan Zhang, Yan-Bo Ren, Kai Wei, Jue Hong, Yan-Ting Yang, Li-Jie Wu, Ji Zhang, Zheng Shi, Huan-Gan Wu, Xiao-Peng Ma
    World Journal of Gastroenterology.2018; 24(30): 3384.     CrossRef
  • How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
    You Sun Kim
    The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
  • Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn’s Disease
    Eun Soo Kim, Sung Kook Kim, Byung Ik Jang, Kyeong Ok Kim, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Sang Gyu Kwak
    Digestive Diseases and Sciences.2018; 63(9): 2220.     CrossRef
  • Efficacy of herb-partitioned moxibustion at Qihai (CV 6) and bilateral Tianshu (ST 25) on colonic damage and the TLR4/NF-κB signaling pathway in rats with Crohn's disease
    Zhang Dan, Wei Kai, Ma Xiaopeng, Wu Huangan, Hong Jue, Zhang Cuihong, Wu Lingxiang, Yan Huang, Liu Jie, Zhu Yi, Yang Ling
    Journal of Traditional Chinese Medicine.2018; 38(2): 218.     CrossRef
  • Novel treatments for inflammatory bowel disease
    Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
    The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
  • Rapid rise in the incidence and clinical characteristics of pediatric inflammatory bowel disease in a South–East Asian cohort in Singapore, 1994–2015
    Christina Ong, Marion M Aw, Maria J Liwanag, Seng H Quak, Kong B Phua
    Journal of Digestive Diseases.2018; 19(7): 395.     CrossRef
  • Urbanization and the gut microbiota in health and inflammatory bowel disease
    Tao Zuo, Michael A. Kamm, Jean-Frédéric Colombel, Siew C. Ng
    Nature Reviews Gastroenterology & Hepatology.2018; 15(7): 440.     CrossRef
  • Molecular diagnosis and classification of inflammatory bowel disease
    Hu Zhang, Zhen Zeng, Arjudeb Mukherjee, Bo Shen
    Expert Review of Molecular Diagnostics.2018; 18(10): 867.     CrossRef
  • Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis
    Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee
    Intestinal Research.2018; 16(2): 216.     CrossRef
  • Predictors and clinical outcomes of follow‐up loss in patients with inflammatory bowel disease
    Dae Hyung Woo, Kyeong Ok Kim, Min Kyu Kang, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
    Journal of Gastroenterology and Hepatology.2018; 33(11): 1834.     CrossRef
  • Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
    Saransh Jain, Saurabh Kedia, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Peush Sahni, Sujoy Pal, Nihar Ranjan Dash, Govind Makharia, Simon P. L. Travis, Vineet Ahuja
    Intestinal Research.2018; 16(1): 69.     CrossRef
  • Risk factors for inflammatory bowel disease: A prospective multi-center study
    Anjali D. Amarapurkar, Deepak N. Amarapurkar, Pravin Rathi, Prabha Sawant, Nikhil Patel, Praful Kamani, Krishnakant Rawal, Rajiv Baijal, Ameya Sonawane, Nitin Narawane, Samrat Kolekar, Naveen Totla
    Indian Journal of Gastroenterology.2018; 37(3): 189.     CrossRef
  • Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
    Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi
    Intestinal Research.2018; 16(2): 233.     CrossRef
  • Genomic characterization of colitis-associated colorectal cancer
    Hitoshi Kameyama, Masayuki Nagahashi, Yoshifumi Shimada, Yosuke Tajima, Hiroshi Ichikawa, Masato Nakano, Jun Sakata, Takashi Kobayashi, Sumana Narayanan, Kazuaki Takabe, Toshifumi Wakai
    World Journal of Surgical Oncology.2018;[Epub]     CrossRef
  • Changing treatment paradigms for the management of inflammatory bowel disease
    Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
    The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
  • Significant Medical and Surgical Morbidity in Perianal Crohn’s Disease: Results from a Territory-Wide Study
    Wing Yan Mak, Oi Sze Mak, Choon Kin Lee, Whitney Tang, Wai Keung Leung, Marc T L Wong, Alex Shun Fung Sze, Michael Li, Chi Man Leung, Fu Hang Lo, Belsy C Y Lam, Kam Hon Chan, Edwin Hok Shing Shan, Steven Woon Choy Tsang, Aric J Hui, Wai Hung Chow, Francis
    Journal of Crohn's and Colitis.2018;[Epub]     CrossRef
  • Neat1-miRNA204-5p-PI3K-AKT axis as a potential mechanism for photodynamic therapy treated colitis in mice
    Kunpeng Wang, Zijian Zhang, Kai Liu, Xin Yang, Heng Zou, Jiangjiao Zhou, Xiongying Miao, Wei Chen, Li Xiong, Yu Wen
    Photodiagnosis and Photodynamic Therapy.2018; 24: 349.     CrossRef
  • Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
    Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim
    World Journal of Gastroenterology.2018; 24(42): 4798.     CrossRef
  • Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies
    Garima Juyal, Ajit Sood, Vandana Midha, B. K. Thelma
    Journal of Genetics.2018; 97(5): 1493.     CrossRef
  • Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
    Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Gut and Liver.2018; 12(5): 544.     CrossRef
  • Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease
    Christina Ong, Poh Ting Lim, Veena Logarajah, Maria Janelle Liwanag, Bi Xia Ang, Yuqin Cher, Fang Kuan Chiou, Ajmal Kader
    BMC Gastroenterology.2018;[Epub]     CrossRef
  • Incidence and clinical outcomes of intestinal Behçet’s disease in Korea, 2011–2014: a nationwide population-based study
    Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
    Journal of Gastroenterology.2017; 52(8): 920.     CrossRef
  • Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: A retrospective study
    Dong Juan Song, Jin Lu Tong, Jiang Chen Peng, Chen Wen Cai, Xi Tao Xu, Ming Ming Zhu, Zhi Hua Ran, Qing Zheng
    Journal of Digestive Diseases.2017; 18(1): 23.     CrossRef
  • Role of MiRNAs in Inflammatory Bowel Disease
    Bo Cao, Xin Zhou, Jiaojiao Ma, Wei Zhou, Wanli Yang, Daiming Fan, Liu Hong
    Digestive Diseases and Sciences.2017; 62(6): 1426.     CrossRef
  • Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
    Jean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet
    Gastroenterology.2017; 152(2): 351.     CrossRef
  • Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
    Jong Pil Im
    Intestinal Research.2017; 15(2): 147.     CrossRef
  • Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
    Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chi
    Intestinal Research.2017; 15(3): 285.     CrossRef
  • Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
    Chang Soo Eun
    Intestinal Research.2017; 15(2): 145.     CrossRef
  • Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease
    Jee Hyun Kim, Ji Won Kim
    Korean Journal of Gastroenterology.2017; 70(4): 162.     CrossRef
  • Second Korean guidelines for the management of Crohn's disease
    Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
    Intestinal Research.2017; 15(1): 38.     CrossRef
  • Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia
    Eun Soo Kim
    Intestinal Research.2017; 15(1): 5.     CrossRef
  • Tofacitinib for Ulcerative Colitis — A Promising Step Forward
    Sonia Friedman
    New England Journal of Medicine.2017; 376(18): 1792.     CrossRef
  • Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
    Toshifumi Hibi, Yuya Imai, Yoko Murata, Nobuko Matsushima, Richuan Zheng, Christopher Gasink
    Intestinal Research.2017; 15(4): 475.     CrossRef
  • Clinical course of ulcerative colitis patients who develop acute pancreatitis
    Jong Wook Kim, Sung Wook Hwang, Sang Hyoung Park, Tae Jun Song, Myung-Hwan Kim, Ho-Su Lee, Byong Duk Ye, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
    World Journal of Gastroenterology.2017; 23(19): 3505.     CrossRef
  • Second Korean Guidelines for the Management of Crohn's Disease
    Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
    The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
  • Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
    Eun Hye Oh, Dae-Hyun Ko, Hyungil Seo, Kiju Chang, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
    World Journal of Gastroenterology.2017; 23(8): 1489.     CrossRef
  • An update on diagnostic and prognostic biomarkers in inflammatory bowel disease
    Andrew S. Day, Steven T. Leach, Daniel A. Lemberg
    Expert Review of Molecular Diagnostics.2017; 17(9): 835.     CrossRef
  • Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
    Suraj Kumar, Sawan Bopanna, Saurabh Kedia, Pratap Mouli, Rajan Dhingra, Rajesh Padhan, Mikashmi Kohli, Jigyasa Chaubey, Rohini Sharma, Prasenjit Das, S Dattagupta, Govind Makharia, SK Sharma, Vineet Ahuja
    Intestinal Research.2017; 15(2): 187.     CrossRef
  • Second Korean Guideline for the Management of Ulcerative Colitis
    Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
    The Korean Journal of Gastroenterology.2017; 69(1): 1.     CrossRef
  • Factors associated with pregnancy-related knowledge in women of reproductive age with inflammatory bowel disease
    Ko Eun Lee, Sung-Ae Jung, Hyuk Yoon, Sang Hyoung Park, Chang Mo Moon, Eun Soo Kim, Seong-Eun Kim, Suk-Kyun Yang
    Scandinavian Journal of Gastroenterology.2017; 52(8): 833.     CrossRef
  • Malignant Melanoma of the Anus Found during Routine Colonoscopy in Ulcerative Colitis
    Kwang Il Seo, Won Moon, Sung Eun Kim, Moo In Park, Seun Ja Park
    The Korean Journal of Gastroenterology.2017; 69(6): 368.     CrossRef
  • Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner
    Changhyun Lee, Byeong Gwan Kim, Jee Hyun Kim, Jaeyoung Chun, Jong Pil Im, Joo Sung Kim
    International Immunopharmacology.2017; 51: 47.     CrossRef
  • Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study
    Yoon Suk Jung, Minkyung Han, Won Ho Kim, Sohee Park, Jae Hee Cheon
    Digestive Diseases and Sciences.2017; 62(8): 2102.     CrossRef
  • Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study
    Yoon Suk Jung, Minkyung Han, Sohee Park, Won Ho Kim, Jae Hee Cheon
    Journal of Crohn's and Colitis.2017; 11(8): 954.     CrossRef
  • Second Korean guidelines for the management of ulcerative colitis
    Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
    Intestinal Research.2017; 15(1): 7.     CrossRef
  • Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors
    Eun Hye Oh, Kyunghwan Oh, Minkyu Han, Hyungil Seo, Kiju Chang, Sun-Ho Lee, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
    PLOS ONE.2017; 12(5): e0177479.     CrossRef
  • Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease
    Yehyun Park, Jae Hee Cheon, Yi Lang Park, Byong Duk Ye, You Sun Kim, Dong Soo Han, Joo Sung Kim, Sung Noh Hong, Young Ho Kim, Seong Ran Jeon, Won Ho Kim
    Inflammatory Bowel Diseases.2017; 23(7): 1071.     CrossRef
  • RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohnʼs Disease Patients Compared with Normal Mucosa of Healthy Controls
    Sung Noh Hong, Je-Gun Joung, Joon Seol Bae, Chan Soo Lee, Ja Seol Koo, Soo Jung Park, Jong Pil Im, You Sun Kim, Ji Won Kim, Woong Yang Park, Young-Ho Kim
    Inflammatory Bowel Diseases.2017; 23(7): 1098.     CrossRef
  • The Phase 3 Trials of Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
    Sang Hyoung Park
    The Korean Journal of Gastroenterology.2017; 69(1): 90.     CrossRef
  • Role of Smoking as a Risk Factor in East Asian Patients with Crohn's Disease
    Sung Chul Park, Yoon Tae Jeen
    Gut and Liver.2017; 11(1): 7.     CrossRef
  • Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life
    Jin Young Yoon, Jeong Eun Shin, Sang Hyoung Park, Dong Il Park, Jae Myung Cha
    Gut and Liver.2017; 11(3): 370.     CrossRef
  • Practice patterns and clinical significance of use of capsule endoscopy in suspected and established Crohn's disease
    Yonghyun Kim, Seong Ran Jeon, Sang Myung Choi, Hyun Gun Kim, Tae Hee Lee, Jun-Hyung Cho, Yunho Jung, Wan Jung Kim, Bong Min Ko, Jin-Oh Kim, Joon Sung Lee, Moon Sung Lee
    Intestinal Research.2017; 15(4): 467.     CrossRef
  • Epidemiology, Natural History, and Risk Stratification of Crohn's Disease
    Satimai Aniwan, Sang Hyoung Park, Edward V. Loftus
    Gastroenterology Clinics of North America.2017; 46(3): 463.     CrossRef
  • Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis
    Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Seong Woo Jeon, Hyun Jin Kim, Sung Kook Kim
    Digestive Diseases and Sciences.2017; 62(9): 2489.     CrossRef
  • Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
    Jung Won Lee
    Gut and Liver.2017; 11(4): 449.     CrossRef
  • Pivot to Asia: inflammatory bowel disease burden
    Prashant Singh, Ashwin Ananthakrishnan, Vineet Ahuja
    Intestinal Research.2017; 15(1): 138.     CrossRef
  • Temporal Trend of Pediatric Inflammatory Bowel Disease
    Takashi Ishige, Takeshi Tomomasa, Reiko Hatori, Maiko Tatsuki, Yoshiko Igarashi, Kazuhiko Sekine, Hirokazu Arakawa
    Journal of Pediatric Gastroenterology and Nutrition.2017;[Epub]     CrossRef
  • Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease
    Hyun Ho Choi, Young-Seok Cho
    Gut and Liver.2017; 11(3): 319.     CrossRef
  • X Chromosome-wide Association Study Identifies a Susceptibility Locus for Inflammatory Bowel Disease in Koreans
    Ho-Su Lee, Hyunjung Oh, Suk-Kyun Yang, Jiwon Baek, Seulgi Jung, Myunghee Hong, Kyung Mo Kim, Hyoung Doo Shin, Kyung-Jo Kim, Sang Hyoung Park, Byong Duk Ye, Buhm Han, Kyuyoung Song
    Journal of Crohn's and Colitis.2017; 11(7): 820.     CrossRef
  • Asians Have More Perianal Crohn Disease and Ocular Manifestations Compared with White Americans
    Bharati Kochar, Edward L. Barnes, Hans H. Herfarth, Christopher F. Martin, Ashwin N. Ananthakrishnan, Dermot McGovern, Millie D. Long, Robert S. Sandler
    Inflammatory Intestinal Diseases.2017; 2(3): 147.     CrossRef
  • NF-kappa B activation correlates with disease phenotype in Crohn’s disease
    Yoo Min Han, Jaemoon Koh, Ji Won Kim, Changhyun Lee, Seong-Joon Koh, ByeongGwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim, Gernot Sellge
    PLOS ONE.2017; 12(7): e0182071.     CrossRef
  • Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity
    Jung Hwan Oh
    Journal of Neurogastroenterology and Motility.2016; 22(4): 545.     CrossRef
  • Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I
    Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa
    BMJ Open Gastroenterology.2016; 3(1): e000122.     CrossRef
  • 12,184 View
  • 250 Download
  • 234 Web of Science
  • 244 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP